Patent · US Active

Nucleoside analogs

US8551973B2 · kind B2 · utility

67Cited by
219References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2009
Grant dateOct 8, 2013
Priority date—
Expiry dateFeb 17, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A purified compound having activity against hepatitis C virus is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.